Abstract
Introduction
Sickle cell disease results from a single glutamic acid to valine substitution at position 6 of the beta globin polypeptide chain. Sickling was first discovered by Linus Pauling and colleagues in 1949 1 . It is inherited as an autosomal recessive trait 2 . The disease mainly occurs in Africans (25% carry the gene). But is also found in India, the Middle East, and Southern Europe 3, 4 . When haemoglobin S is deoxygenated, the molecules of hemoglobin polymerise to form pseudocrystalline structures known as 'tactoids'. These distort the red cell membrane and produce characteristic sickle shaped cells. The polymerization is reversible when re-oxygenation occurs. The distortion of the red cell membrane, however, may become permanent and the red cell 'irreversibly sickled'. This process may be enchanced or retarded by the presence of other hemoglobins. Thus, the abnormal hemoglobin C variant participates in the polymerization more readily than haemoglobin A, whereas haemoglobin F strongly inhibits polymeriastion. These abnormalities provoke unpredictable episodes of microvascular vasoocclusion and premature RBC destruction (hemolytic anaemia) 5, 6 . Hemolysis occurs because the spleen destroys the abnormal RBC. The rigid adherent cells also clog small capillaries and venules, causing tissue ischaemia, acute pain, and gradual end-organ damage 7 .
This sickle cell anaemia 9 . Repeated acute chest syndrome episodes may also predispose to scarring and pulmonary hypertension 10 . It is unclear that the patients with sickle cell disease are more prone to nephrotic syndrome, but the histological picture of membranoproliferative glomerulonephritis accounts for over one half of adult cases 11 . Patients with sickle cell anaemia adapt well to their low hemoglobin levels and regular blood transfusion is not required 12 .
Case report 1:
A 18 years old male with acute onset of pain in bones and joints for last 6 days and recurrent attacks of pallor, weakness and fatigue for last 10 years. On physical examination temperature -101 0 F, pulse rate -120 beats/min, respiratory rate -32 cycles/min, blood pressure -120/82 mm Hg, pallor present and mild oedema present, Cardiovascular system -normal heart sounds, no murmur, Respiratory system -bilateral crepitations, abdomenhepatoslenomegaly present. (Fig -6 ): HbA2-4.7%, HbF-23.9%,HbS-71.4% on fully automated Capillarys 2flex piercing system.
Fig -6: Haemoglobin electrophoresis.
With above Haemoglobin electrophoresis and haemogram report this case was diagnosed as a case of Sickle cell disease with vaso-conclusive crisis. This patient was treated with oxygen inhalation, IV fluid, blood transfusion, antibiotics, analgesics. With this treatment patient recovered well and discharged.
Discussion
Sickle cell disease is characterized by the pathophysiological feature of chronic haemolytic anaemia, vaso-occlusion resulting in ischemic tissue injury and painful episodes 13 . Vaso-occlusion may result from exercise, stress, dehydration, cold exposer, high altitude, smoking and infections 14, 15 . Among the infections Parvovirus B19 infection is common and may leads to aplastic crisis 16, 17 . The organs of great risk are the spleen, kidney and bone marrow where oxygen tension is low and blood flow is diminished. Sickle cell disease usually presents as vaso-occlusive crisis, acute chest syndrome, hemolytic anaemia, chronic leg ulcer, stroke and nephrotic syndrome 18 . These two patients presented with anaemia and vasoocclusive crisis. The definitive diagnosis requires hemoglobin electrophoresis to demonstrate the absence of HbA, 2-20% of HbF and the presence of HbS 19 . In these cases hemoglobin electrophoresis shows the presence of HbF (19% and 23.9,%) and Hb S (48.3% and 71.4%). The peripheral blood smear is characteristically abnormal with irreversibly sickled cells comprising 5-50% of red cells 20 . Peripheral blood smear from this patient shows sickle cells. Sickle cell patients have a known predisposition to bacterial infection, particularly pneumococcal infection [21] [22] [23] . Parvovirus B19 infection in these cases are not evaluated as investigations facilities such as antibody of parvovirus identification or PCR are not available in our hospital and local setup. These patients treated with blood transfusion, antibiotics, analgesics, folic acid, diuretics and oxygen inhalation. Both patients were treated conservatively and response was well. The most significant advance in the therapy of sickle cell anaemia has been the introduction of Hydroxyurea. And Hydroxyurea is given to case no.1 as he is suffering for long time with recurrent attack of Pallor requiring blood transfusion and hospitalization. But hydroxyurea is not given in Case no 2 as his response to treatment was well and have less frequent attacks and are in close observation for follow up 24 . Hydroxyurea was not given to case 2 as detailed clinical data of previous attacks are lacking from first episode and growth and development of parameter are well. With the above treatment patient recovered well, discharged and review after ten days in the OPD revealed that the patient was healthy. Hence even in vaso-occlusive disorder of sickle cell disease patient's recovery is good with early diagnosis and effective treatment 25 . Recent advancement in sickle cell disease treatment include anti adhesion therapy, monoclonal antibody and autologus stem cell base therapy, which can be use for treatment of disease or its complications 26, 27 .
Conclusion
SCD is a chronic debilitating disease characterized by recurrent episodes of ischemia -reperfusion injury and is the most common cause of overt stroke in children. Sickle cell infarcts (SCI) occur in approximately onequarter of children with SCD prior to their 6 th birthday and approximately one-third prior to their 14 th birthday. The lifetime risk of stroke in a patient with SCD lies between 25% and 30%, with 75% being arterial ischemic strokes while 24% of patients with SCD have suffered at least one episode of stroke by the age of 45. Silent or subtle strokes are common and may occur in up to 50% of patients with SCD. Here case no-1 celebrate his 18 th birthday and case no-2 celebrate his 6 th birthday without any cerebrovascular events. This make us hopeful for better outcome of these cases.
